Frontlight ResearchEarly access
Trial site
Shandong Cancer Hospital & institute
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer4 trials
- Lung cancer4 trials
- Cervical cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Endometrial cancer2 trials
- Ovarian cancer2 trials
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Phase 1/23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed4 trials
- Recruiting4 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Hutchmed3 trials
- RemeGen Co., Ltd.2 trials
- Betta Pharmaceuticals Co., Ltd.1 trial
- CStone Pharmaceuticals1 trial
- Daiichi Sankyo1 trial
- and 5 more
Running trials
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Gastric and oesophageal cancer2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026